Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.


Updates from The Motley Fool

Latest updates on Ligand Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Ligand Pharmaceuticals.
3 Hot Stocks to Buy in July

A banking behemoth, a social media giant, and an under-the-radar biotech company appear to be siz...

3 Stocks to Invest in Healthcare

Masimo, CVS Health, and Ligand Pharmaceuticals stand out as great healthcare stock picks for long...

5 Growth Stocks to Buy in March

Investors are starting to flock back toward growth stocks, and these companies could benefit.

The Best Value Stocks of 2015

The stock market may have been relatively flat for the year, but these three value stocks surged ...



Stock Performance

View Interactive LGND Charts
Sponsored by

Key Data Points

Primary metrics and data points about Ligand Pharmaceuticals.
Current Price: $127.97
Prev Close: $126.55
Open: $127.25
Bid: $120.28
Ask: $129.90
Day's Range: $126.16 - $128.19
52wk Range: $87.50 - $129.94
Volume: 181,514
Avg Vol 224,885
Market Cap: $3B
P/E (ttm): 10.04
EPS (ttm): $12.61
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Ligand Pharmaceuticals.
CAPS Rating 3 out of 5
 
187 Outperform
25 Underperform
CAPS All Stars
 
33 Outperform
9 Underperform

How do you think Ligand Pharmaceuticals will perform against the market?



You pick for Ligand Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John L. Higgins, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Ligand Pharmaceuticals.

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers